Search Results for "Growth"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Growth. Results 131 to 140 of 296 total matches.

Shockwave Therapy for Erectile Dysfunction

   
The Medical Letter on Drugs and Therapeutics • Nov 27, 2023  (Issue 1690)
microtrauma that leads to expression of vascular endothelial growth factor.2 The frequency of treatment ...
Low-intensity extracorporeal shockwave therapy similar to that used to fragment kidney stones or gallstones is a new option for treatment of erectile dysfunction that is now being advertised extensively in the US. It has not been approved by the FDA for treatment of erectile dysfunction.
Med Lett Drugs Ther. 2023 Nov 27;65(1690):190-1   doi:10.58347/tml.2023.1690d |  Show IntroductionHide Introduction

Daprodustat (Jesduvroq) for Anemia of Chronic Kidney Disease

   
The Medical Letter on Drugs and Therapeutics • Feb 19, 2024  (Issue 1696)
/day. Increased levels of HIF may stimulate cancer growth; use of daprodustat is not recommended ...
The FDA has approved daprodustat (Jesduvroq – GSK), a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for oral treatment of anemia due to chronic kidney disease (CKD) in adults who have been on dialysis for at least 4 months. It is the first HIF-PHI and the first oral drug to be approved in the US for this indication.
Med Lett Drugs Ther. 2024 Feb 19;66(1696):25-7   doi:10.58347/tml.2024.1696a |  Show IntroductionHide Introduction

OTC Drugs for Seasonal Allergies

   
The Medical Letter on Drugs and Therapeutics • Apr 22, 2019  (Issue 1570)
for ≥12 months in children has been associated with small decreases in growth velocity.3,4 ...
Patients with seasonal allergies often experience nasal itching and congestion, sneezing, rhinorrhea, and itchy, watery eyes. Oral, intranasal, and ophthalmic preparations are widely available over the counter (OTC) for relief of symptoms. Prescription products for management of allergic rhinitis and allergic conjunctivitis are reviewed separately.
Med Lett Drugs Ther. 2019 Apr 22;61(1570):57-60 |  Show IntroductionHide Introduction

Methylphenidate Revisited

   
The Medical Letter on Drugs and Therapeutics • May 06, 1988  (Issue 765)
insomnia and anorexia, however, usually diminish with time even when moderate doses are continued. Growth ...
Methylphenidate (Ritalin and others), a Schedule II controlled substance in the USA, is a short-acting central-nervous-system stimulant widely used for treatment of children with school performance or behavior problems, or what is now called Attention Deficit-Hyperactivity Disorder, or AD-HD (American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, third ed., revised [DSM-III R], Washington, DC:authors, 1987, p 50). Some studies have estimated that more than 3% of elementary school students are taking methylphenidate, and one parents' group has brought a...
Med Lett Drugs Ther. 1988 May 6;30(765):51-2 |  Show IntroductionHide Introduction

Treatment of Clostridium Difficile Diarrhea

   
The Medical Letter on Drugs and Therapeutics • Oct 20, 1989  (Issue 803)
Clin Microbiol, 27:889, 1989). Selective growth media have also been used to culture C. difficile ...
The gram-positive bacillus Clostridium difficile is the most common identifiable cause of antibiotic-associated diarrhea and pseudomembranous colitis (R Fekety in GL Mandell et al, eds, Principles and Practice of Infectious Diseases, 3rd ed, New York:Churchill Livingstone, 1990, page 863). C. difficile colitis usually develops during or soon after antibiotic treatment. Virtually any antimicrobial agent can cause the disorder, but clindamycin, ampicillin and the cephalosporins have been implicated most frequently. Pseudomembranous colitis was recently reported in five patients who had ...
Med Lett Drugs Ther. 1989 Oct 20;31(803):94-5 |  Show IntroductionHide Introduction

A Subdermal Progestin Implant For Long-Term Contraception

   
The Medical Letter on Drugs and Therapeutics • Mar 08, 1991  (Issue 839)
development and growth, and may suppress progesterone secretion during the luteal phase. EFFECTIVENESS ...
The Norplant System (Wyeth-Ayerst) for subdermal delivery of the synthetic progestin levonorgestrel was recently approved by the US Food and Drug Administration for use as a long-term contraceptive.
Med Lett Drugs Ther. 1991 Mar 8;33(839):17-8 |  Show IntroductionHide Introduction

BCG For Bladder Cancer

   
The Medical Letter on Drugs and Therapeutics • Apr 05, 1991  (Issue 841)
growth. The exact mechanism of antitumor activity is unknown, but live BCG provokes an inflammatory ...
BCG Live (TheraCys - Connaught) and BCG Vaccine U.S.P. (TiceBCG - Organon), freeze-dried suspensions of an attenuated strain of Mycobacterium bovis, were recently approved by the US Food and Drug Administration for intravesical treatment of primary or relapsed carcinoma in situ of the bladder, with or without associated papillary tumors. BCG is not recommended for treatment of papillary tumors occurring alone.
Med Lett Drugs Ther. 1991 Apr 5;33(841):29-30 |  Show IntroductionHide Introduction

Autologous Bone marrow Transplantation For Advanced Breast Cancer

   
The Medical Letter on Drugs and Therapeutics • May 03, 1991  (Issue 843)
in the hospital in reverse isolation. Giving the patient the newly available hematopoietic growth factors G-CSF ...
The prognosis in breast cancer is generally poor for women with unresectable, locally advanced disease (inflammatory cancer or more than 10 positive lymph nodes) and for those with metastases. Autologous bone marrow transplantation - removing bone marrow from multiple sites under general anesthesia, giving high-dose chemotherapy with or without total body radiation, and reinfusing the bone marrow intravenously - is being tried in some of these patients.
Med Lett Drugs Ther. 1991 May 3;33(843):39-40 |  Show IntroductionHide Introduction

Aerosolized Deoxyribonuclease for Cystic Fibrosis

   
The Medical Letter on Drugs and Therapeutics • Apr 15, 1994  (Issue 920)
. It requires a nebulizer to produce an aerosol mist for inhalation. STANDARD TREATMENT — Bacterial growth ...
Recombinant human deoxyribonuclease I (rhDNase; dornase alfa; Pulmozyme - Genentech), an enzyme that hydrolyzes extracellular DNA, is now available as a purified solution to decrease the viscosity of sputum in patients with cystic fibrosis. It requires a nebulizer to produce an aerosol mist for inhalation.
Med Lett Drugs Ther. 1994 Apr 15;36(920):34-5 |  Show IntroductionHide Introduction

Peripheral-Blood Stem-Cells Transplants

   
The Medical Letter on Drugs and Therapeutics • Aug 18, 1995  (Issue 955)
cancer chemotherapy and administration of hematopoietic growth factors such as GM-CSF (granulocyte ...
High-dose chemotherapy, with or without total body radiation, followed by bone marrow transplantation to restore bone marrow function has been used widely in the treatment of malignant diseases in recent years (Medical Letter, 34:79, 1992; 37:25, 1995). Now, however, instead of using bone marrow itself to restore function destroyed by chemotherapy and radiation, many centers infuse hematopoietic stem cells harvested from peripheral blood. Most stem cell transplants have been autologous; allogeneic stem cells have been tried in a small number of patients (WI Bensinger et al, Blood,...
Med Lett Drugs Ther. 1995 Aug 18;37(955):71-2 |  Show IntroductionHide Introduction